Mark R Rigby MD , PhD, FAAP, FCCM

Research•Philadelphia, PA

Executive Director, Clinical Development, AnaptysisBio (San Diego/Remote)

Join to View Full Profile

NAPhiladelphia, PA 19019

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Critical Care Medicine, 2000 - 2003
Johns Hopkins UniversityResidency, Pediatrics, 1997 - 2000
University of Massachusetts Medical SchoolClass of 1997
Duke UniversityBS, Biology, 1987 - 1991

Certifications & Licensure

IN State Medical License 2011 - 2015
GA State Medical License Active through 2013

Awards, Honors, & Recognition

Society for Pediatric Research 2009
Fellow (FCCM) American College of Critical Care Medicine

Clinical Trials

Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children Start of enrollment: 2006 Oct 01
Completed
Not Applicable
Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab Start of enrollment: 2008 Oct 01
Withdrawn
Phase 2
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial Start of enrollment: 2009 Sep 01
Completed
Not Applicable
Inducing Remission in Type 1 Diabetes With Alefacept Start of enrollment: 2011 Mar 01
Terminated
Phase 2
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients Start of enrollment: 2010 Jun 01
Completed
Phase 2, Phase 3
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry Start of enrollment: 2010 May 01
Completed
Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial Start of enrollment: 2010 Aug 01
Completed
Phase 3
Hypothermia's Impact on Pharmacology Start of enrollment: 2012 Mar 01
Completed
Heart And Lung Failure - Pediatric INsulin Titration Trial Start of enrollment: 2012 Apr 01
Completed
Phase 3
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT) Start of enrollment: 2012 Oct 01
Completed
Join now to see all

Publications & Presentations

PubMed

116 citations
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Teresa Quattrin, Michael J. Haller, Andrea K. Steck, Eric I. Felner, Yinglei Li
The New England Journal of Medicine. 2020-11-18
21 citations
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data fr...
Ashley Pinckney, Mark R. Rigby, Lynette Keyes-Elstein, Carol L. Soppe, Gerald T. Nepom
Clinical Therapeutics. 2016-06-01
2 citations
Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes
Karen D. Boyle, Lynette Keyes-Elstein, Mario R. Ehlers, James McNamara, Mark R. Rigby
Diabetes Care. 2016-04-13

Press Mentions

COVID-19 Has Pushed Hospitals to the Limit - but Could Reshape the NHS of the FutureMarch 11th, 2021
Provention Bio : Appoints Leading T1D Expert, Dr. Mark Rigby, as Vice President, Clinical DevelopmentJuly 31st, 2018

Professional Memberships

American College of Critical Care Medicine - SCCM
Fellow